A Southern Research neuroscience lab has received new federal grants totaling almost $3.9 million to advance its study of Parkinson’s Disease and other neurological diseases. The grants from the National […]
We're Solving the World's
Hardest Problems
Find Out How
About Southern Research
We’ve created seven drugs that are helping win the war on cancer. More are on the way. When HIV threatened the world’s future, we helped develop a course of treatment that changed the course of history. We’re creating better ways for you to have cleaner air and water. Our technologies help men and women in uniform remain safe overseas. We’re developing methods to build energy efficient cars out of plant fiber that will get 80mpg. We are Southern Research. We’re taking on the world’s hardest problems. And solving them. This has been our mission since 1941.
And we’re just getting started.
Upcoming Events
Recent Stories
Birmingham’s Southern Research under new leadership
Josh Carpenter, PhD, has been appointed president and CEO and Allen Bolton executive vice president for strategy and finance at Birmingham-based Southern Research. The scientific discovery and research institution employs […]
Birmingham’s Southern Research appoints CEO, EVP
Southern Research, the groundbreaking scientific discovery and research institution headquartered in Birmingham, on Thursday announced that its board of directors has appointed Josh Carpenter, Ph.D., as its new president and […]
Southern Research selects new president and CEO
Birmingham’s Southern Research announced today that Josh Carpenter will be its new president and CEO, effective June 1. Allen Bolton will also serve as its new executive vice president for […]
Southern Research Appoints Josh Carpenter as President and CEO and Allen Bolton as Executive VP for Strategy and Finance
Two prominent Birmingham leaders have been named to leadership posts at Southern Research – the scientific discovery and research institution headquartered on Birmingham’s Southside. Josh Carpenter has been named president […]
Southern Research and Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results
Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission TNX-1800 is Based on a Proprietary Vaccine Platform Designed […]